EUVIMEDObjevte EUVIMED
ÜbersichtsarbeitOpen access · CC BY 4.0

Unraveling mitochondria‐targeting reactive oxygen species modulation and their implementations in cancer therapy by nanomaterials

Haibao Peng, Feibai Yao, Jiaxu Zhao, Wei Zhang, Lingchao Chen, Xin Wang, Peng Yang iD, Jing Tang, Yudan Chi

Exploration · 2023-04 · 3 (2)

DOI: 10.1002/exp.20220115 ↗

At a glance

Übersichtsarbeit in Exploration, published online on 2023-04-05. Written by Haibao Peng and 8 co-authors. Institution: Department of Neurosurgery, Huashan Hospital, Institute for Translational Brain Research, State Key Laboratory of Medical Neurobiology, MOE Frontiers…. Cited 137 times so far (Crossref); 95 references. The full text is freely available (open access, CC BY 4.0). Funded by: Natural Science Foundation of Shanghai, American Association for Cancer Research, Fundamental Research Funds for the Central Universities.

AbstraktSubjectsBibliografické údajeCiteRelated studies

Abstract (original language)

Functional subcellular organelle mitochondria are emerging as a crucial player and driver of cancer. For maintaining the sites of cellular respiration, mitochondria experience production, and accumulation of reactive oxygen species (ROS) underlying oxidative damage in electron transport chain carriers. Precision medicine targeting mitochondria can change nutrient availability and redox homeostasis in cancer cells, which might represent a promising strategy for suppressing tumor growth. Herein, this review highlights how the modification capable of manipulating nanomaterials for ROS generation strategies can influence or compensate the state of mitochondrial redox homeostasis. We propose foresight to guide research and innovation with an overview of seminal work and discuss future challenges and our perspective on the commercialization of novel mitochondria‐targeting agents.

Subjects

Author keywords

cancer therapymitochondria‐targetingnanomaterialsreactive oxygen species

Authors and institutions

  • Department of Neurosurgery, Huashan Hospital, Institute for Translational Brain Research, State Key Laboratory of Medical Neurobiology, MOE Frontiers Center for Brain Science Fudan University Shanghai China.
  • Engineering Research Center of Molecular- and Neuro-imaging of Ministry of Education, School of Life Science and Technology Xidian University Xi'an Shaanxi China.
  • Department of Materials Science and Engineering Stanford University Stanford California USA.

ORCID profiles: Peng Yang

Funding

  • Natural Science Foundation of Shanghai
  • American Association for Cancer Research
  • Fundamental Research Funds for the Central Universities

Cite

APA

Peng, H., Yao, F., Zhao, J., Zhang, W., Chen, L., Wang, X., Yang, P., Tang, J., & Chi, Y. (2023). Unraveling mitochondria‐targeting reactive oxygen species modulation and their implementations in cancer therapy by nanomaterials. Exploration, 3(2). https://doi.org/10.1002/exp.20220115

Vancouver

Peng H, Yao F, Zhao J, Zhang W, Chen L, Wang X, et al. Unraveling mitochondria‐targeting reactive oxygen species modulation and their implementations in cancer therapy by nanomaterials. Exploration. 2023;3(2). doi:10.1002/exp.20220115

BibTeX
@article{Peng2023,
  author = {Peng, Haibao and Yao, Feibai and Zhao, Jiaxu and Zhang, Wei and Chen, Lingchao and Wang, Xin and Yang, Peng and Tang, Jing and Chi, Yudan},
  title = {Unraveling mitochondria‐targeting reactive oxygen species modulation and their implementations in cancer therapy by nanomaterials},
  journal = {Exploration},
  year = {2023},
  volume = {3},
  number = {2},
  doi = {10.1002/exp.20220115}
}
Start for free →